Patents by Inventor David Irani

David Irani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ethylene propylene copolymer compounds for use in layered articles
    Patent number: 11965085
    Abstract: A multilayer structure can include at least one layer that comprises an ethylene propylene diene copolymer compound that comprises: 60 parts per hundred rubber (phr) to 95 phr of a first ethylene propylene diene copolymer (EP(D)M) having an ethylene content of 62 wt % to 90 wt % based on the first EP(D)M and a heat of fusion (Hf) of 15 J/g or greater; 5 phr to 40 phr of an second EP(D)M having an ethylene content of 40 wt % to 60 wt % based on the second EP(D)M and a Hf of 0 J/g to 14 J/g, wherein the Hf of the first EP(D)M minus the Hf of the second EP(D)M is 5 J/g or greater; wherein the first EP(D)M and second EP(D)M combined are 100 parts; a filler at 40 phr to 500 phr; and a curing agent at 0.5 phr to 20 phr.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: April 23, 2024
    Assignee: ExxonMobil Engineering & Technology Company
    Inventors: Zhifeng Bai, Scott H. Loyd, Narayanaswami Dharmarajan, Rainer Kolb, David W. Abmayr, Jr., Khodabakhsh Irani
  • Methods for diagnosis and optimizing treatment of multiple sclerosis
    Patent number: 8114619
    Abstract: Biological markers for multiple sclerosis, and their use in the diagnosis and prognosis of the disease, are described. Also described are methods for treating multiple sclerosis by administering an inhibitor of cathepsin B activity or a neuroprotective composition comprising a modified terpenoid compound. Also described are isolated polypeptide biomarkers, polynucleotides encoding the polypeptide biomarkers, and antibodies that bind specifically to the polypeptide biomarkers. Further described are kits that include the above-mentioned isolated polypeptide biomarkers, the polynucleotides encoding them, or specific antibodies against the polypeptide biomarkers.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: February 14, 2012
    Assignee: The Johns Hopkins University
    Inventors: Avindra Nath, Caroline F Anderson, David Irani, Robert J Cotter, Joseph P Steiner, Norman Haughey
  • Methods and Compositions for Diagnosis and Treatment of Multiple Sclerosis
    Publication number: 20100137420
    Abstract: Biological markers for multiple sclerosis, and their use in the diagnosis and prognosis of the disease, are described. Also described are methods for treating multiple sclerosis by administering an inhibitor of cathepsin B activity or a neuroprotective composition comprising a modified terpenoid compound. Also described are isolated polypeptide biomarkers, polynucleotides encoding the polypeptide biomarkers, and antibodies that bind specifically to the polypeptide biomarkers. Further described are kits that include the above-mentioned isolated polypeptide biomarkers, the polynucleotides encoding them, or specific antibodies against the polypeptide biomarkers.
    Type: Application
    Filed: September 19, 2007
    Publication date: June 3, 2010
    Inventors: Avindra Nath, Caroline F. Anderson, David Irani, Robert J. Cotter, Joseph P. Steiner, Norman Haughey